Topic: Moderna

CAMBRIDGE, Ma. — Moderna has no plans to share the recipe for its COVID-19 vaccine because executives have concluded that scaling up the company’s own production is the best way to increase the global supply, the company’s chairman[...]

CAMBRIDGE, Ma. — Moderna co-founder and chairman Noubar Afeyan — an American entrepreneur of Armenian descent — has made to this year’s Forbes list of the 400 richest people in the United States. Landing the 212th with an estimated[...]

NEW YORK — Bishop Daniel Findikyan, Primate of the Eastern Diocese of the Armenian Church of America, was elected by unanimous vote to the board of directors of the Appeal of Conscience Foundation, the New York-based humanitarian[...]

By Elizabeth Cohen, John Bonifield and Jamie Gumbrecht, SAVANNAH, Ga. (CNN) — The first Phase 3 clinical trial of a coronavirus vaccine in the United States began Monday, July 27. The investigational vaccine was developed by the[...]

CHICAGO (Reuters) — A study of Moderna Inc’s COVID-19 vaccine in mice lends some assurance that it will not increase the risk of more severe disease, and that one dose may provide protection against the novel coronavirus, according[...]

By Denise Grady SEATTLE (New York Times) — The first testing in humans of an experimental vaccine for the new coronavirus began on Monday, March 16, the National Institute of Allergy and Infectious Diseases announced. The main goal of[...]